α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk

Chest

Volumn 128, Issue 1, 2005, Pages 445-452

  Yang, Ping ^a   Bamlet, William R ^a   Sun, Zhifu ^a   Ebbert, Jon O ^a   Aubry, Marie Christine ^a   Taylor, William R ^a   Marks, Randolph S ^a   Deschamps, Claude ^a   Swensen, Stephen J ^a   Wieben, Eric D ^b   Cunningham, Julie M ^a   Melton, Lee Joseph ^a   De Andrade, Mariza ^a  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Chronic obstructive; Leukocyte elastase; Lung neoplasm; Pulmonary disease; Tobacco smoking; 1 antitrypsin deficiency

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE; PROTEINASE INHIBITOR; TOBACCO SMOKE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ANALYSIS; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENDER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; ISOELECTRIC FOCUSING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY; ALPHA 1 ANTITRYPSIN DEFICIENCY; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

AGED; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKOCYTE ELASTASE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 22244461873     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.445     Document Type: Article

References (40)

1. Tobacco smoking. IARC Monogr Eval Carcinog Risks Hum. 1986; 38:35-394
2. Blot WJ, Fraumeni JF Jr. Cancers of the lung and pleura. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiol Prev. New York, NY: Oxford University Press, 1996; 637-665
3. Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health 1987; 77:425-431
4. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003; 95:470-478
5. Ebbert JO, Yang P, Vachon CM, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003; 21:921-926
6. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 1996; 144:554-562
7. Alavanja MCR, Brownson RC, Boice JD, et al. Preexisting lung disease and hing cancer among nonsmoking women. Am J Epidemiol 1992; 136:623-632
8. Cohen BH, Graves CG, Lew DA, et al. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977; 2:523-526
9. Sun Z, Yang P. Neutrophil elastase and alpha-1 antitrypsin: the role of imbalance in cancer development and progression; a review. Lancet Oncol 2004; 5:182-190
10. Taniguchi K, Yang P, Jett J, et al. Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clin Cancer Res 2002; 8:1115-1120
11. 1-Antitrypsin deficiency allele carriers in lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999; 8:461-465
12. Yang P, Yokomizo A, Tazelaar HD, et al. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer 2002; 35:221-229
13. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71:266-274
14. de Andrade M, Ebbert JO, Wampfler JA, et al. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 2004; 43:127-134
15. Allen RC, Harley RA, Talamo RC. A new model for determination of alpha-1-antitrypsin phenotypes using isolectric focusing on polyacrylamide gel slabs. Am J Clin Pathol 1974; 62:732-739
16. Tietz NW, Finley PR, Pruden EL, et al. General clinical tests. In: Tietz NW, Finley PR, Pruden EL, eds. Clinical guide to laboratory tests. Philadelphia, PA: WB Saunders Co, 1990; 68-69
17. 1-Antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited disease. New York, NY: The McGraw-Hill Companies, 1995; 4125-4158
18. 1-antitrypsin, INSERUM, Rouen/Bois-Guillaume-1978. Hum Genet 1980; 53:429-433
19. Crystal RG. The alpha-1 antitrypsin gene and its deficiency state. Trends Genet 1989; 5:411-417
20. Zimmer M, Medcalf RL, Fink TM, et al. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A 1992; 89:8215-8219
21. Pilat D, Fink TM, Obennaier-Skrobanek B, et al. The human met-ase gene (GZMM): structure, sequence, and close physical linkage to the serine protease gene cluster on 19p13.3. Genomics 1994; 24:445-450
22. Sohni YR, Dukek B, Taylor WF, et al. Active electronic arrays for genotyping NAT2 polymorphisms. Clin Chem 2001; 1922-1924
23. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2001; 70:425-434
24. Agresti A. Categorical data analysis. New York, NY: John Wiley & Sons, 1990
25. Breslow NE, Day NE. The analysis of case-control studies. Statistical methods in cancer research. Lyon, France: IARC Scientific Publications, 1980; Publication No. 32
26. Hosmer DW, Lemeshow S. Applied logistic regression. New-York, NY: John Wiley & Sons, 1989
27. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49:1373-1379
28. Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002; 3:299-309
29. Stram D, Pearce C, Bretsky P, et al. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for case-control study of unrelated individuals. Hum Hered 2003; 55:179-190
30. Lake S, Lyon H, Silverman EK, et al. Estimation and tests of haploptype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55:56-65
31. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control AC 1974; 19:716-723
32. Needham M, Stockley RA. Alpha 1-antitrypsin deficiency: 3. Clinical manifestations and natural history. Thorax 2004; 59:441-445
33. Weinrauch Y, Drujan D, Shapiro SD, et al. Neutrophil elastase targets virulence factors of enterobacteria. Nature 2002; 417:91-94
34. Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999; 23:433-436
35. Ancliff PJ, Gale RE, Liesner R, et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98:2645-2650
36. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96:2317-2322
37. Aprikyan AA. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol 2001; 13:535-538
38. Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem 2001; 276:14230-14241
39. Yoshimura K, Chu CS, Crystal RG. Enhancer function of a 53-bp repetitive element in the 5′ flanking region of the human neutrophil elastase gene. Biochem Biophys Res Commun 1994; 204:38-42
40. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748